CHOP/Penn Study Shows CAR-T Cells Remain Active a Decade After Infusion
Feb 2, 2022
A new study in Nature has documented the longest persistence of CAR T cell therapy to date.
Your child will be cared for by one of the most accomplished teams of childhood cancer experts in the world. We provide medical care, emotional counseling and much more. We make sure your child, you and every family member get the highest level of support.
Feb 2, 2022
A new study in Nature has documented the longest persistence of CAR T cell therapy to date.
Jan 28, 2022
Tracey Jubelirer, MD, is the Medical Director of the inpatient oncology unit at the Middleman Family Pavilion at Children’s Hospital of Philadelphia, King of Prussia.
Jan 27, 2022
CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.
Jan 20, 2022
To help children through cancer treatment, yoga therapy is offered at our Voorhees and King of Prussia Specialty Care Centers.
Jan 19, 2022
CHOP researchers have found that implementation science is underused in pediatric oncology and call for more research in this area to improve patient care.
Jan 4, 2022
Aberrant splicing leads to downregulation of CD22 in pediatric B-ALL, rendering malignant cells resistant to the effects of CD22-directed immunotherapies.
Dec 20, 2021
Researchers have unlocked patterns to improve the diagnosis of the most common epigenetic childhood cancer disorder.
Dec 13, 2021
A cell and gene therapy expert, Grupp discussed progress in clinical care in the 50 years since the legislation was signed.
Nov 24, 2021
Parents of a precious child lost to cancer are determined to find a cure.
Nov 10, 2021
CHOP’s annual Parkway Run & Walk, presented by Citadel, raised over $1.6 million to support childhood cancer research and care at Children’s Hospital of Philadelphia (CHOP)